QbD Group acquires Rescop, expanding its Software Solutions & Services division and strengthening its presence in the Netherlands, Poland, Germany, Switzerland and the US.

QbD Group today announces the acquisition of Rescop, a specialist in GxP compliance, computer system validation, and validation software for the life sciences industry.

Antwerp, Belgium / Baarle-Nassau, the Netherlands – 12 May 2026 – QbD Group, a leading international life sciences consultancy firm, today announces the acquisition of Rescop, a specialist in GxP compliance, computer system validation (CSV), and validation software for the life sciences industry. The acquisition strengthens QbD Group's end-to-end service offering, adds a proprietary software portfolio to the group, and reinforces its presence in the Netherlands and Poland.

"This acquisition is a natural next step in our QbDream. QbD Group has always been strong in regulatory affairs, clinical services, and qualification and validation consultancy. Rescop brings deep expertise in GxP compliance and computer system validation, perfectly complementing what we offer. Together, we can deliver even more comprehensive, end-to-end solutions to our clients across the life sciences," said Bart Van Acker, CEO of QbD Group.

Rescop brings a proprietary software product to the group: e-VLM, a tool that enables data-driven validation and paperless compliance, fully aligned with the FDA's Computer Software Assurance (CSA) principles. This proven, market-ready product expands QbD Group's software offering and strengthens its position as a technology-driven life sciences partner.

Complementary expertise, stronger together

QbD Group's strengths in regulatory affairs, clinical services, and qualification and validation consultancy are a natural fit with Rescop's specialization in GxP compliance, CSV, and life sciences IT services. Together, the two organizations cover a broader share of the product lifecycle, giving clients access to more integrated support from a single, trusted partner.

A stronger future for Rescop employees

Joining QbD Group opens new horizons for Rescop's approximately 85 team members across the Netherlands, Poland, Lithuania, Turkey and the U.S. As part of a larger international organization, team members gain access to global projects, professional development opportunities, and a network of over 600 colleagues across Europe, North America, and beyond.

Björn Aalbers, Founder and CEO of Rescop, takes on the role of Managing Partner – Strategic Accounts, having a commercial focus on key accounts at a global level, combined with the role of Country Manager Netherlands within QbD Group. All other leadership positions remain unchanged, ensuring continuity for clients and employees alike.

Uninterrupted service and greater value for clients

For Rescop's clients, business continuity is the top priority. Clients can expect the same high level of service, with no immediate changes to account management or ongoing projects. As part of QbD Group, Rescop will now be able to offer a broader range of integrated services, from CSV and GxP compliance to regulatory affairs, quality assurance, and clinical services.

"Joining QbD Group is the right next step for Rescop, our team, and our clients. We have been deliberate in looking for a partner that shares our values, understands our market, and is committed to keeping what makes Rescop strong. In QbD Group, we found exactly that, and I look forward to everything we will achieve together," said Björn Aalbers, Managing Partner – Strategic Accounts / Country Manager Netherlands, QbD Group.

Expanding QbD Group's reach across the Netherlands, Poland, and beyond

With this acquisition, QbD Group surpasses 100 employees in the Netherlands, combining the existing QbD Group Netherlands team with Rescop's Dutch workforce. The Kraków office adds a second Polish location alongside Warsaw, where QbD Group is already active following the acquisition of SciencePharma. Rescop is also active across three continents: Europe, North America, and Asia, further strengthening QbD Group's international reach.

About Rescop

Rescop is a global provider of GxP compliance software and consulting services, helping regulated companies in the life sciences work in a lean, paperless way and continuously improve the maturity of their processes. Its e-VLM software suite covers the full system lifecycle, including commissioning, qualification, and validation, and is used by leading companies such as Charles River Laboratories and CordenPharma. Complementing its software offering, Rescop delivers GxP compliance services worldwide, including qualification, validation, and inspection readiness, as well as training through Rescop Academy. With offices across multiple continents, Rescop operates as a true one-stop partner for GxP compliance. For more information, visit rescop.com.